Parmax Pharma P/B Ratio
Parmax Pharma (PARMAX) P/B ratio is -6.55 (Low), book value per share ₹-15.00 vs Healthcare average P/B of 0.14 — Very Low - Significant discount to book value, potential distress or value opportunity. For live price, earnings yield and the full fundamental profile, see PARMAX screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
PARMAX P/B Ratio — Valuation Insights & Book Value Analysis
Parmax Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B -6.55 (Low). Read Parmax Pharma dividend policy for the complete payout history and dividend yield track record.
- Stock appears undervalued with PB of -6.55, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 320.5% below historical average
- Trading at discount to sector average PB of 0.14
Parmax Pharma P/B Ratio Historical Trend
PARMAX annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore Parmax Pharma intrinsic worth to estimate fundamental worth using multiple valuation models.
PARMAX Historical P/B Ratio — Book Value Per Share & Year-End Price
Parmax Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2023 | 2.71 | ₹12.0 | ₹32.57 | ₹6 | Moderate |
| 2022 | 3.23 | ₹12.0 | ₹38.70 | ₹6 | High |
PARMAX vs Healthcare Peers — P/B Ratio Comparison
Parmax Pharma P/B -6.55 vs Healthcare average 0.14, median 0.67 — range -6.32–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |
| Dipna Pharmachem | DPL | 0.2 | ₹12 | Low |